FIXX - Homology Medicines EPS beats by $0.08 beats on revenue November, 15 2021 07:55 AM Homology Medicines Inc. Homology Medicines (NASDAQ:FIXX): Q3 GAAP EPS of -$0.54 beats by $0.08. Revenue of $1.67M (+193.0% Y/Y) beats by $0.87M. Press Release For further details see: Homology Medicines EPS beats by $0.08, beats on revenue